Skip to main content
Year archive

Formycon AG — 2015 filings

All 13 regulatory filings released by Formycon AG (FYB) in 2015, sourced directly from the official regulator.

13 Filings
2015 Period
2015 filings (13)
Filing Released Lang
Formycon AG: Formycon announces results for first nine months of 2015
Earnings Release 9M 2015
2015-11-10 English
Formycon AG: Global strategic partners bioeq and Formycon initiate pivotal phase III clinical trial with their Lucentis(R) biosimilar
Regulatory Filings
2015-10-07 English
Formycon announces positive financial results for first half of 2015
Earnings Release H1 2015
2015-09-14 English
Half-yearly Report 2015
Interim / Quarterly Report H2 2015
2015-09-14 German
Formycon AG receives favorable scientific advice from U.S. Food and Drug Administration for its partnered biosimilar candidate FYB201
Regulatory Filings
2015-07-22 English
Jahresabschluss 2014
Annual Report FY 2014
2015-06-08 German
Formycon AG: Results announced for 1Q 2015, forecast raised for full-year 2015
Earnings Release Q1 2015
2015-06-02 English
Formycon AG signs licensing agreement for its FYB203 biosimilar
Regulatory Filings
2015-05-28 English
Formycon AG: Carsten Brockmeyer belongs to the top 20 most influential people in the Global 'Medicine Maker Power List' 2015
Board/Management Information
2015-05-19 English
Formycon AG: Reappointment of board member Dr. Nicolas Combe
Board/Management Information
2015-05-04 English
Formycon AG successfully completes capital increase from approved capital
Capital/Financing Update
2015-04-16 English
Formycon Group announces preliminary results for fiscal year 2014
Earnings Release FY 2014
2015-03-30 English
Formycon AG announces successful GMP inspection and the start of US FDA scientific advice procedure for its out-licensed biosimilar FYB201
Regulatory Filings
2015-03-09 English